2021 Investor Day

Growing the market through commercial excellence and expanding market access Continuing to drive growth in our core channels Driving commercial innovation in new channels and through partnerships Generating clinical and economic evidence in sleep apnea and COPD and asthma © 2021 ResMed | 2021 Investor Day - Sept 8, 2021 Strong history of market development and growth 17

View entire presentation